Available Structures
242 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| tau-microtubule structural ensemble based on CryoEM data |
Heteromer P02554; Q2XVP4; | 100 | 7×GDP; 7×GTP; 7×MG; | |||
| tau-microtubule structural ensemble based on CryoEM data |
Heteromer P02554; Q2XVP4; | 100 | 7×GDP; 7×GTP; 7×MG; | |||
| Structure of 14-3-3 zeta delta C with the bivalent tau-pS214-pS324 peptide |
Heteromer P63104; | 100.0 | ||||
| Model of synthetic tau (R2x4) bound to the microtubule |
Heteromer P02554; Q2XVP4; | 100 | 2×GDP; 1×GTP; 1×MG; | |||
| Structure of tau peptide in complex with Tau5 antibody Fab fragment |
Heteromer A2NHM3; | 100 | 5×SO4; 4×NA; 1×PGE; | |||
| CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY PT3 Fab+pT212/pT217-TAU PEPTIDE |
Heteromer | 100 | 1×GOL; | |||
| Crystal structure of anti-tau antibody dmCBTAU-28.1, double mutant (S32R, E35K) of CBTAU-28.1, in c… |
Heteromer | 100 | 1×CL; | |||
| SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH HUMAN TAU PHOSPHOTHREONINE PEPTIDE |
Heteromer Q13526; | 92.31 | ||||
| VHH H3-2 in complex with Tau C-terminal peptide |
Heteromer | 100 | ||||
| Crystal structure of human anti-tau antibody CBTAU-28.1 in complex with its tau peptide |
Heteromer | 100 | ||||
| X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATE… |
Heteromer | 100 | ||||
| Model of synthetic tau (four tandem repeats of first repeat sequence) bound to the microtubule |
Heteromer P02554; Q2XVP4; | 100 | 1×GTP; 1×MG; 2×GDP; | |||
| Crystal structure of anti-tau antibody dmCBTAU-27.1, double mutant (S31Y, T100I) of CBTAU-27.1, in … |
Heteromer | 100 | 2×CL; | |||
| Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-medi… |
Heteromer P06241; | 100 | ||||
| Crystal structure of the human CHIP-TPR domain in complex with a 10mer acetylated tau peptide |
Heteromer Q9UNE7; | 100 | ||||
| Structure of the anti-ptau Fab (pT231/pS235_1) in complex with phosphoepitope pT231/pS235 |
Heteromer | 100 | 1×PO4; | |||
| VHH Z70 mutant 3 in interaction with PHF6 Tau peptide |
Heteromer | 90.0 | ||||
| anti-pTau C21-ABS Fab in complex with pTau peptide |
Heteromer | 100 | ||||
| FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 |
Heteromer | 100 | 1×GOL; | |||
| VHH Z70 mutant 20 in interaction with PHF6 Tau peptide |
Heteromer | 100 | ||||
| Anti-TAU AT8 FAB with doubly phosphorylated TAU peptide |
Heteromer | 100 | 2×GOL; | |||
| VHH Z70 mutant 1 in interaction with PHF6 Tau peptide |
Heteromer | 100 | ||||
| Crystal structure of human anti-tau antibody CBTAU-24.1 in complex with its phosphorylated tau pept… |
Heteromer | 100 | ||||
| Crystal structure of DC8E8 Fab in the complex with a 30-mer tau peptide at pH 6.5 |
Heteromer Q52L64; Q99LC4; | 100 | ||||
| Anti-TAU AT8 FAB with triply phosphorylated TAU peptide |
Heteromer | 100 | ||||
| Anti-TAU BIIB092 FAB with TAU peptide |
Heteromer A2NHM3; | 100 | ||||
| Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 8.5 |
Heteromer | 100 | 1×GLC; 4×PGE; | |||
| Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS214 |
Heteromer P31947; | 100 | 2×CL; 4×MG; 6×CA; 3×GOL; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 126B with 14-3-3sigma |
Heteromer P31947; | 100 | 2×CL; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 109B with 14-3-3sigma |
Heteromer P31947; | 100 | 1×49F; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma |
Heteromer P31947; | 100 | ||||
| Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma |
Heteromer P31947; | 100 | 1×49F; | |||
| Fab/epitope complex of mouse monoclonal antibody C5.2 targeting a phospho-tau epitope. |
Heteromer | 100 | 1×PO4; | |||
| Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 6.5 |
Heteromer | 100 | ||||
| Crystal structure of Tau and acetylated tau peptide antigen |
Heteromer | 100 | ||||
| Crystal structure of DC8E8 Fab in the complex with a 14-mer tau peptide at pH 7.5 |
Heteromer | 100 | ||||
| Crystal structure of C-terminal modified Tau peptide-hybrid 4.2e-I with 14-3-3sigma |
Heteromer P31947; | 100 | 7×NA; 2×D3W; 2×CL; | |||
| Crystal structure of the human CHIP-TPR domain in complex with a 6mer acetylated tau peptide |
Heteromer Q9UNE7; | 100 | ||||
| Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-I with 14-3-3sigma |
Heteromer P31947; | 100 | 5×NA; 2×D3Q; 2×CL; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 4.2c-I with 14-3-3sigma |
Heteromer P31947; | 100 | 2×CL; 1×MG; 2×NA; 2×D3K; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 4.2f-II with 14-3-3sigma |
Heteromer P31947; | 100 | 2×CL; 4×NA; 2×D4K; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 4.2b with 14-3-3sigma |
Heteromer P31947; | 100 | 2×CL; 4×NA; 2×D4H; | |||
| The complex structure of PHF core domain peptide of tau and antibody's Fab domain. |
Heteromer | 100 | ||||
| Fab/epitope complex of mouse monoclonal antibody 6B2 targeting a non-phosphorylated tau epitope. |
Heteromer | 100 | 1×PO4; | |||
| Fab/epitope complex of human chimeric monoclonal antibody h4E6 targeting a phosphorylated tau epito… |
Heteromer | 100 | 1×GOL; 1×PO4; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 3.2d with 14-3-3sigma |
Heteromer P31947; | 100 | 2×CL; 2×MG; 8×NA; 2×60H; | |||
| Fab/epitope complex of mouse monoclonal antibody 8B2 targeting a non-phosphorylated tau epitope. |
Heteromer | 100 | 3×GOL; 1×PO4; | |||
| Crystal structure of human 14-3-3 sigma in complex with a Tau-protein peptide surrounding pS324 |
Heteromer P31947; | 100 | 4×MG; 2×CA; 2×CL; | |||
| Crystal structure of C-terminal modified Tau peptide-hybrid 3.2e with 14-3-3sigma |
Heteromer P31947; | 100 | 2×CA; 2×CL; 2×NA; 2×60H; | |||
| Acetylated tau repeat 1 and 2 fragment (AcR1R2) | homo-48-mer | 100 | ||||
| Structure of the Tau-PAM4 Type 1 amyloid fibril | homo-36-mer | 86.67 | ||||
| Structure of the Fmoc-Tau-PAM4 Type 4 amyloid fibril | homo-24-mer | 100 | ||||
| Structure of the Fmoc-Tau-PAM4 Type 3 amyloid fibril | homo-24-mer | 100 | ||||
| Alzheimer's disease paired-helical filament in complex with PET tracer GTP-1 | homo-23-mer | 100 | 23×Y9H; | |||
| Structure of the Fmoc-Tau-PAM4 Type 2 amyloid fibril | homo-18-mer | 100 | ||||
| KVQIINKKLD, Structure of the amyloid spine from microtubule associated protein tau Repeat 2 | homo-18-mer | 100 | ||||
| VQIINK, Structure of the amyloid-spine from microtubule associated protein tau Repeat 2 | homo-18-mer | 100 | ||||
| First Intermediate Amyloid (FIA) - Tau | homo-16-mer | 100 | ||||
| RNA-induced tau amyloid fibril | homo-15-mer | 100 | ||||
| Tau - AD-LIA4 (tau intermediate amyloid) | homo-12-mer | 100 | ||||
| In vitro assembled tau filaments into Quadruple Helical Filaments type 1 (2c) | homo-12-mer | 100 | ||||
| In vitro assembled 297-394 tau filaments, 700 rpm (34b) | homo-12-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with MgCl2 and NaCl (14b) | homo-12-mer | 100 | ||||
| Globular glial tauopathy type 2 tau filament | homo-10-mer | 100 | ||||
| Limbic-predominant neuronal inclusion body 4R tauopathy type 2 tau filament | homo-10-mer | 100 | ||||
| Globular glial tauopathy type 3 tau filament | homo-10-mer | 100 | ||||
| Argyrophilic grain disease type 2 tau filament | homo-10-mer | 100.0 | ||||
| Conformation 2 of straight filament from primary age-related tauopathy brain | homo-10-mer | 100 | ||||
| Paired helical filament from primary age-related tauopathy brain | homo-10-mer | 100 | ||||
| Conformation 1 of straight filament from primary age-related tauopathy brain | homo-10-mer | 100 | ||||
| Tau Paired Helical Filament from Alzheimer's Disease incubated with EGCG for 3 hours | homo-10-mer | 100 | 10×KDH; | |||
| Paired helical tau filament extracted from GSS Patient brain tissue | tau filament from Gerstmann S… | homo-10-mer | 100 | ||||
| CTE type III tau filament from vacuolar tauopathy | homo-10-mer | 100 | ||||
| Tau Paired Helical Filament from Alzheimer's Disease not incubated with EGCG | homo-10-mer | 100 | ||||
| Tau Paired Helical Filament from Alzheimer's Disease incubated 1 hr. with EGCG | homo-10-mer | 100 | ||||
| Straight tau filaments in dominantly inherited Alzheimer disease with cotton wool plaques | homo-10-mer | 98.65 | ||||
| Paired helical tau filament extracted from PrP-CAA Patient brain tissue | tau filament | PHF Tau | homo-10-mer | 100 | ||||
| Pronase-treated paired helical filament in Alzheimer's disease brain | homo-10-mer | 100 | ||||
| Straight filament in Alzheimer's disease brain | homo-10-mer | 100 | ||||
| Paired helical filament in Alzheimer's disease brain | homo-10-mer | 100 | ||||
| Straight tau filament extracted from PrP-CAA Patient brain tissue | tau filament | SF Tau | homo-10-mer | 100 | ||||
| PHF Tau from Down Syndrome | homo-10-mer | 100 | ||||
| SF Tau from Down Syndrome | homo-10-mer | 100 | ||||
| Paired helical tau filaments in dominantly inherited Alzheimer disease with cotton wool plaques | homo-10-mer | 100 | ||||
| Temperature-dependent structures of tau aggregates | homo-10-mer | 100 | ||||
| Tau (297-391) in vitro untwisted fibril | homo-10-mer | 100 | ||||
| KVQIINKKL, crystal structure of a tau protein fragment | homo-10-mer | 100 | ||||
| SVQIVY, Crystal Structure of a tau protein fragment | homo-10-mer | 100 | ||||
| Tau - AD-MIA7 (tau intermediate amyloid) | homo-9-mer | 100 | ||||
| Tau - AD-THF | homo-9-mer | 100 | ||||
| Tau - AD-MIA11 | homo-9-mer | 100 | ||||
| THF filament generated from 4E-Tau(297-407) under neutral Mg2+ condition | homo-9-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with KCl (10a) | homo-9-mer | 100 | 18×CL; 18×K; | |||
| Tau - CTE-LIA14 (tau intermediate amyloid) | homo-9-mer | 100 | ||||
| In vitro assembled tau filaments with MgSO4 and NaCl (15a) | homo-9-mer | 100 | ||||
| In vitro assembled 305-379 tau filaments (27a) | homo-9-mer | 100 | ||||
| MicroED structure of tau VQIVYK peptide at 1.1 A resolution | homo-9-mer | 100 | ||||
| Structure of an amyloid forming peptide VQIVYK from the second repeat region of tau (alternate poly… | homo-8-mer | 100 | ||||
| PHF tau filament from Kii ALS/PDC | homo-7-mer | 100 | ||||
| Tau Paired Helical Filament from Cellular Fraction of Alzheimer's disease brain | homo-7-mer | 100 | ||||
| Tau Paired Helical Filament from Extracellular Vesicles from Alzheimer's disease brain | homo-7-mer | 100 | ||||
| AT8-Phosphomimetic Tau Filaments (Full-length, Cofactor-Free 0N4R Tau S202E, T205E, S208E) | homo-6-mer | 100 | ||||
| Doublet Tau Fibril from Corticobasal Degeneration Human Brain Tissue | homo-6-mer | 100 | ||||
| Cryo-EM structure of TypeII tau filaments extracted from the brains of individuals with Corticobasa… | homo-6-mer | 100 | ||||
| Alzheimer's Disease Seeded 0N3R Tau Fibrils | homo-6-mer | 100 | ||||
| Alzheimer's Disease Seeded Mixed 0N4R and 0N3R Tau Fibrils | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with KCl (10b) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA11 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-MIA2 | homo-6-mer | 100 | ||||
| Paired helical filament from sporadic Alzheimer's disease brain | homo-6-mer | 100 | ||||
| Heparin bound Tau fibril polymorph 4 | homo-6-mer | 100 | ||||
| Straight filament from sporadic Alzheimer's disease brain | homo-6-mer | 100 | ||||
| PHF type tau filament from R406W mutant | homo-6-mer | 100 | ||||
| Tau - CTE-MIA5 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau: AD-MIA1 | homo-6-mer | 100 | ||||
| Straight Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide an… | homo-6-mer | 100 | ||||
| Paired Helical Filaments purified from Down Syndrome individual brain tissue applied to graphene ox… | homo-6-mer | 100 | ||||
| Straight Filament of tau amyloids found in Down Syndrome individuals | homo-6-mer | 100 | ||||
| Paired Helical Filament of tau amyloids found in Down Syndrome individuals | homo-6-mer | 100 | ||||
| in vitro assembled 266/297 - 391 tau filaments with MgCl2 and NaCl (14a) | homo-6-mer | 100 | ||||
| In vitro assembled 297-408 S396D S400D T403D S404D tau filaments (42a) | homo-6-mer | 100 | ||||
| Cryo-EM structure of in vitro PHF fibril | homo-6-mer | 100 | ||||
| Heparin bound Tau fibril PHF | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with NaHCO3 and NaCl (16a) | homo-6-mer | 100 | ||||
| Heparin bound Tau fibril polymorph 3 | homo-6-mer | 100 | ||||
| Tau - AD-LIA5 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-PHF | homo-6-mer | 100 | ||||
| Tau - AD-LIA7 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-LIA8 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-PHF long crossover | homo-6-mer | 100 | ||||
| in vitro assembled tau filaments with structures like Paired Helical Filaments from Alzheimer's Dis… | homo-6-mer | 100 | ||||
| Tau - AD-LIA2 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-LIA6 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with ZnCl2 (11a) | homo-6-mer | 100 | ||||
| Recombinant tau PHF filaments (peptide synthesis 291-391) | homo-6-mer | 100 | ||||
| In vitro assembled tau filaments with structures like chronic traumatic encephalopathy type II (8a) | homo-6-mer | 100 | ||||
| CTE typeII tau filament from Guam ALS/PDC | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with LiCl (9a) | homo-6-mer | 100 | ||||
| Chronic traumatic encephalopathy Type I Tau filament | homo-6-mer | 100 | ||||
| Tau - AD-MIA10 (intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA14 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| CTE typeIII tau filament from Guam ALS/PDC | homo-6-mer | 100 | ||||
| CTE typeIII tau filament | homo-6-mer | 100 | ||||
| Chronic traumatic encephalopathy Type II Tau filament | homo-6-mer | 100 | ||||
| Tau - CTE-MIA15 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| CTE type II tau filament from vacuolar tauopathy | homo-6-mer | 100 | ||||
| Tau - AD-MIA5 | homo-6-mer | 100 | ||||
| Tau - AD-MIA8 (intermediate amyloid) | homo-6-mer | 100 | ||||
| Chronic traumatic encephalopathy tau filaments with PET ligand flortaucipir | homo-6-mer | 100 | 6×S9C; | |||
| Tau - CTE-MIA3 | homo-6-mer | 100 | ||||
| Structure of Tau filaments Type II from Subacute Sclerosing Panencephalitis | homo-6-mer | 100 | ||||
| Tau - CTE-MIA7 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-MIA3 | homo-6-mer | 100 | ||||
| Tau - CTE-MIA13 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| In vitro assembled 297-394 tau filaments in PBS (35d) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA4 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA8 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Alzheimer's disease PHF complexed with PET ligand MK-6240 | homo-6-mer | 100 | 6×X6R; | |||
| Tau - CTE-type I (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| CTE tau intermediate amyloid (LIA-17) | homo-6-mer | 100 | ||||
| CTE type II (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| PHF type tau filament from in vitro V337M mutant | homo-6-mer | 98.65 | ||||
| In vitro assembled 266/297 - 391 tau filaments with LiCl (9b) | homo-6-mer | 100 | ||||
| Tau - AD-MIA6 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA6 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| PHF filament generated from 4E-Tau(297-407) under neutral Mg2+ condition | homo-6-mer | 100 | ||||
| Paired helical tau filaments from high-spin supernatants of aqueous extracts from Alzheimer's disea… | homo-6-mer | 100 | ||||
| Tau - CTE-LIA5 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-LIA4 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-LIA7 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with MgSO4 and NaCl (15b) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA18 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - AD-MIA4 | homo-6-mer | 100 | ||||
| Tau - CTE-MIA10 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA9 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| In vitro assembled 300-391 tau filaments in PBS (36a) | homo-6-mer | 100 | ||||
| Tau - CTE-MIA1 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| in vitro assembled 266/297 - 391 tau filaments with NaCl (8b) | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with MgSO4 and NaCl (15c) | homo-6-mer | 100 | ||||
| Tau - CTE-LIA3 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| Tau - CTE-LIA13 (tau intermediate amyloid) | homo-6-mer | 100 | ||||
| In vitro assembled 0N4R tau filaments with phosphoserine (47a) | homo-6-mer | 100 | ||||
| Cryo-EM structure of amyloid fibril formed by tau (297-391) | homo-6-mer | 100 | ||||
| Cofactor-free Tau 4R2N isoform | homo-6-mer | 100 | ||||
| In vitro assembled 266/297 - 391 tau filaments with CuCl2 (12a) | homo-6-mer | 100 | ||||
| In vitro assembled 266-391 S356D tau filaments with NaCl (45a) | homo-6-mer | 100 | ||||
| In vitro assembled 266-391 S356D tau filaments with KCl (44a) | homo-6-mer | 100 | ||||
| In vitro assembled 258-391 tau filaments with sodium azide, (41a) | homo-6-mer | 100 | ||||
| Cryo-EM structure of heparin-induced 2N3R tau filaments | homo-6-mer | 96.43 | ||||
| Structure of an amyloid forming peptide VQIVYK from the TAU protein in complex with orange G | homo-6-mer | 100 | 12×ZN; 6×ACY; 6×ORA; | |||
| RQEFEV, crystal structure of the N-terminal segment RQEFEV from protein tau | homo-6-mer | 100 | ||||
| Argyrophilic grain disease type 1 tau filament | homo-5-mer | 100 | ||||
| Progressive supranuclear palsy tau filament | homo-5-mer | 100 | ||||
| Globular glial tauopathy type 1 tau filament | homo-5-mer | 100 | ||||
| Limbic-predominant neuronal inclusion body 4R tauopathy type 1b tau filament | homo-5-mer | 100 | ||||
| Limbic-predominant neuronal inclusion body 4R tauopathy type 1a tau filament | homo-5-mer | 100 | ||||
| PHF1-Phosphomimetic Tau Filaments (Full-length, Cofactor-Free 0N4R Tau S396E, S400E, T403E, S404E) | homo-5-mer | 100 | ||||
| Paired helical filament from Alzheimer's disease with PET ligand APN-1607 | homo-5-mer | 100 | ||||
| Straight filament from Alzheimer's disease with PET ligand APN-1607 | homo-5-mer | 100 | ||||
| CTE typeI tau filament from Kii ALS/PDC | homo-5-mer | 100 | ||||
| TypeII tau filament from Kii ALS/PDC | homo-5-mer | 100 | ||||
| CTE type I tau filament from vacuolar tauopathy | homo-5-mer | 100 | ||||
| Structure of Tau filaments Type I from Subacute Sclerosing Panencephalitis | homo-5-mer | 100 | ||||
| CTE typeI tau filament from Guam ALS/PDC | homo-5-mer | 100 | ||||
| Temperature-dependent structures of tau aggregates | homo-5-mer | 100 | ||||
| P301T type I tau filaments from human brain | homo-4-mer | 99.06 | ||||
| Structure of an amyloid forming peptide VQIVYK from the repeat region of Tau | homo-4-mer | 100 | ||||
| High-resolution map of tau filament from progressive supranuclear palsy (PSP) case 1 | homo-3-mer | 100 | ||||
| Cryo-EM structure of SH-SY5Y seeded with filaments from Alzheimer's Disease | homo-3-mer | 100 | ||||
| Singlet Tau Fibril from Corticobasal Degeneration Human Brain Tissue | homo-3-mer | 100 | ||||
| Cryo-EM structure of TypeI tau filaments extracted from the brains of individuals with Corticobasal… | homo-3-mer | 100 | ||||
| P301L tau filaments from human brain | homo-3-mer | 99.06 | ||||
| Cryo-EM structure of SH-SY5Y seeded with filaments from corticobasal degeneration extracts | homo-3-mer | 100 | ||||
| P301T type II tau filaments from human brain | homo-3-mer | 98.96 | ||||
| Narrow Pick Filament from Pick's disease brain | homo-3-mer | 91.49 | ||||
| P301S Tau Filaments from the Brains of PS19 Transgenic Mouse Line | homo-3-mer | 98.94 | ||||
| Cryo-EM structure of SH-SY5Y seeded with filaments from corticobasal degeneration extracts (Type II) | homo-3-mer | 100 | ||||
| In vitro assembled 258-391 tau filaments with phosphoglycerate, 700 rpm (39a) | homo-3-mer | 100 | ||||
| In vitro assembled 266-391 tau filaments in PBS (23a) | homo-3-mer | 100 | ||||
| Tau - CTE-LIA6 (tau intermediate amyloid) | homo-3-mer | 100 | ||||
| Tau - CTE-MIA12 (tau intermediate amyloid) | homo-3-mer | 100 | ||||
| In vitro assembled 258-391 tau filaments, 700 rpm (38a) | homo-3-mer | 100 | ||||
| Cryo-EM structure of heparin-induced 2N4R tau snake filaments | homo-3-mer | 100 | ||||
| Cryo-EM structure of human disease-associated P301L Tau amyloid fibril from mouse brain | homo-3-mer | 98.21 | ||||
| In vitro assembled 258-391 tau filaments with heparan sulfate, 700 rpm (40a) | homo-3-mer | 100 | ||||
| In vitro assembled 258-391 tau filaments with phosphoglycerate, 700 rpm (39a) | homo-3-mer | 100 | ||||
| In vitro assembled 244-391 tau filaments with Na2P2O7 (20a) | homo-3-mer | 100 | ||||
| Cryo-EM structure of heparin-induced 2N4R tau twister filaments | homo-3-mer | 100.0 | ||||
| Cryo-EM structure of heparin-induced 2N4R tau jagged filaments | homo-3-mer | 100.0 | ||||
| Straight Filament from Alzheimer's Disease Human Brain Tissue | homo-2-mer | 100 | 2×GLY; | |||
| Paired Helical Filament from Alzheimer's Disease Human Brain Tissue | homo-2-mer | 100 | 4×GLY; | |||
| SF type tau filament from V337M mutant | homo-2-mer | 97.06 | ||||
| SVQIVYK segment from human Tau (305-311) displayed on 54-membered macrocycle scaffold (form II) | homo-2-mer | 87.5 | 2×PO4; 3×MPD; | |||
| SVQIVYK segment from human Tau (305-311) displayed on 54-membered macrocycle scaffold (form I) | homo-2-mer | 87.5 | 3×PO4; | |||
| SVQIVYK segment from human Tau (305-311) displayed on 54-membered macrocycle scaffold (form III) | homo-2-mer | 87.5 | 4×MPD; 1×PO4; | |||
| Tau filaments extracted from human brain with the DeltaK281 mutation in MAPT | monomer | 91.49 | ||||
| PHF type tau filament from V337M mutant | monomer | 97.06 | ||||
| TF type tau filament from V337M mutant | monomer | 97.06 | ||||
| Structure of Tau(267-312) bound to Microtubules | monomer | 100 | ||||
| Structure of Tau(254-290) bound to F-actin | monomer | 100 | ||||
| Structure of Tau(292-319) bound to F-actin | monomer | 100 | ||||
| Structure of Tau(254-268) bound to F-actin | monomer | 100 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8byn.1.F | monomer | 0.56 | 99.32 | |||
| 7qky.1.B | monomer | 0.55 | 99.32 | |||
11 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 9cgz.1.F | monomer | 0.55 | 100.00 | |||
| Isoform 3 | 9cgz.1.F | monomer | 0.52 | 99.03 | |||
| Isoform 4 | 9hbb.1.A | monomer | 0.56 | 94.06 | |||
| Isoform 4 | 8byn.1.F | monomer | 0.56 | 100.00 | |||
| Isoform 5 | 7qky.1.B | monomer | 0.59 | 100.00 | |||
| Isoform 5 | 8ot9.1.B | monomer | 0.51 | 100.00 | |||
| Isoform 6 | 7qky.1.B | monomer | 0.55 | 99.74 | |||
| Isoform 7 | 8byn.1.F | monomer | 0.51 | 100.00 | |||
| Isoform 8 | 7qky.1.B | monomer | 0.55 | 100.00 | |||
| Isoform 9 | 7qky.1.B | monomer | 0.51 | 99.09 | |||
| Isoform 9 | 8byn.1.F | monomer | 0.50 | 99.09 | |||